Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.
about
Eribulin regresses a doxorubicin-resistant Ewing's sarcoma with a FUS-ERG fusion and CDKN2A-deletion in a patient-derived orthotopic xenograft (PDOX) nude mouse model.Targeting altered cancer methionine metabolism with recombinant methioninase (rMETase) overcomes partial gemcitabine-resistance and regresses a patient-derived orthotopic xenograft (PDOX) nude mouse model of pancreatic cancer.Recombinant methioninase combined with doxorubicin (DOX) regresses a DOX-resistant synovial sarcoma in a patient-derived orthotopic xenograft (PDOX) mouse model.
P2860
Targeting methionine with oral recombinant methioninase (o-rMETase) arrests a patient-derived orthotopic xenograft (PDOX) model of BRAF-V600E mutant melanoma: implications for chronic clinical cancer therapy and prevention.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Targeting methionine with oral ...... cancer therapy and prevention.
@en
Targeting methionine with oral recombinant methioninase
@nl
type
label
Targeting methionine with oral ...... cancer therapy and prevention.
@en
Targeting methionine with oral recombinant methioninase
@nl
prefLabel
Targeting methionine with oral ...... cancer therapy and prevention.
@en
Targeting methionine with oral recombinant methioninase
@nl
P2093
P2860
P50
P1433
P1476
Targeting methionine with oral ...... cancer therapy and prevention
@en
P2093
Arun S Singh
Kei Kawaguchi
Kentaro Miyake
Masuyo Miyake
Michiaki Unno
Qinghong Han
Robert M Hoffman
Sarah M Dry
Scott D Nelson
Shukuan Li
P2860
P304
P356
10.1080/15384101.2017.1405195
P577
2018-03-19T00:00:00Z